Anesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston.
Anesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, United States; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Frankfurt.
Haematologica. 2022 Feb 1;107(2):478-488. doi: 10.3324/haematol.2021.278530.
Hepcidin regulates iron homeostasis by controlling the level of ferroportin, the only membrane channel that facilitates export of iron from within cells. Binding of hepcidin to ferroportin induces the ubiquitination of ferroportin at multiple lysine residues and subsequently causes the internalization and degradation of the ligand-channel complex within lysosomes. The objective of this study was to identify components of the ubiquitin system that are involved in ferroportin degradation. A HepG2 cell line, which inducibly expresses ferroportingreen fluorescent protein (FPN-GFP), was established to test the ability of small interfering (siRNA) directed against components of the ubiquitin system to prevent BMP6- and exogenous hepcidin-induced ferroportin degradation. Of the 88 siRNA directed against components of the ubiquitin pathway that were tested, siRNA-mediated depletion of the alternative E1 enzyme UBA6 as well as the adaptor protein NDFIP1 prevented BMP6- and hepcidin-induced degradation of ferroportin in vitro. A third component of the ubiquitin pathway, ARIH1, indirectly inhibited ferroportin degradation by impairing BMP6-mediated induction of hepcidin. In mice, the AAV-mediated silencing of Ndfip1 in the murine liver increased the level of hepatic ferroportin and increased circulating iron. The results suggest that the E1 enzyme UBA6 and the adaptor protein NDFIP1 are involved in iron homeostasis by regulating the degradation of ferroportin. These specific components of the ubiquitin system may be promising targets for the treatment of iron-related diseases, including iron overload and anemia of inflammation.
亚铁调素通过控制铁输出蛋白(唯一能促进细胞内铁输出的膜通道)的水平来调节铁稳态。亚铁调素与铁输出蛋白结合诱导铁输出蛋白在多个赖氨酸残基上发生泛素化,随后导致配体-通道复合物在溶酶体中内化和降解。本研究的目的是鉴定参与铁输出蛋白降解的泛素系统成分。建立了可诱导表达铁蛋白绿色荧光蛋白(FPN-GFP)的 HepG2 细胞系,以测试针对泛素系统成分的小干扰 (siRNA) 防止 BMP6 和外源性亚铁调素诱导的铁输出蛋白降解的能力。在测试的 88 种针对泛素途径成分的 siRNA 中,siRNA 介导的 E1 酶 UBA6 替代酶和衔接蛋白 NDFIP1 的耗竭可防止 BMP6 和亚铁调素体外诱导的铁输出蛋白降解。泛素途径的第三个成分 ARIH1 通过损害 BMP6 介导的亚铁调素诱导,间接抑制铁输出蛋白降解。在小鼠中,AAV 介导的小鼠肝脏中 Ndfip1 的沉默增加了肝脏中铁输出蛋白的水平并增加了循环铁。结果表明,E1 酶 UBA6 和衔接蛋白 NDFIP1 通过调节铁输出蛋白的降解参与铁稳态。这些泛素系统的特定成分可能是治疗铁相关疾病(包括铁过载和炎症性贫血)的有前途的靶点。